Cargando…

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment

Type V hyperlipoproteinemia or multifactorial chylomicronemia syndrome is a rare lipid disorder triggered mainly by uncontrolled diabetes, obesity, poor diet, or particular medications. It is associated with an increased risk of acute pancreatitis and accelerated coronary artery disease which may ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangeshkar, Shaunak, Nazarenko, Natalia, Varrias, Dimitrios, Spanos, Michail, Borkowski, Pawel, Alhuarrat, Majd Al Deen, Li, Weijia, Kishore, Preeti, Faillace, Robert T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403339/
https://www.ncbi.nlm.nih.gov/pubmed/37546045
http://dx.doi.org/10.7759/cureus.41424
_version_ 1785085045578399744
author Mangeshkar, Shaunak
Nazarenko, Natalia
Varrias, Dimitrios
Spanos, Michail
Borkowski, Pawel
Alhuarrat, Majd Al Deen
Li, Weijia
Kishore, Preeti
Faillace, Robert T
author_facet Mangeshkar, Shaunak
Nazarenko, Natalia
Varrias, Dimitrios
Spanos, Michail
Borkowski, Pawel
Alhuarrat, Majd Al Deen
Li, Weijia
Kishore, Preeti
Faillace, Robert T
author_sort Mangeshkar, Shaunak
collection PubMed
description Type V hyperlipoproteinemia or multifactorial chylomicronemia syndrome is a rare lipid disorder triggered mainly by uncontrolled diabetes, obesity, poor diet, or particular medications. It is associated with an increased risk of acute pancreatitis and accelerated coronary artery disease which may manifest in younger age groups. We present a case of a 42-year-old male who presented to the emergency department (ED) complaining of a non-healing hand injury. Upon laboratory workup, the patient was found to have an elevated total cholesterol (TC) of 1129 mg/dL, very low levels of high-density lipoprotein (HDL) and triglycerides (TG) > 4000 mg/dL with an inability to calculate low-density lipoprotein (LDL). Lipoprotein electrophoresis revealed an actual TG level of > 7000 mg/dL, increased chylomicrons, normal B and pre-B-lipoproteins, and increased L-lipoproteins with an elevated Apolipoprotein B. Despite these derangements, the patient did not exhibit any abdominal complaints, demonstrating a normal lipase level. The physical exam was indicative of bilateral arcus senilis and obesity. Insulin drip was initiated along with intravenous (IV) hydration and it required 12 days to bring triglycerides down to less than 1000 mg/dL. The total cholesterol was also seen to be down trending to around 500 mg/dL and the HDL improved to 22 mg/dL. We present this case as a unique presentation of asymptomatic chylomicronemia resistant to insulin treatment with an elevated ApoB but with no evidence of pancreatitis or coronary artery disease.
format Online
Article
Text
id pubmed-10403339
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104033392023-08-06 A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment Mangeshkar, Shaunak Nazarenko, Natalia Varrias, Dimitrios Spanos, Michail Borkowski, Pawel Alhuarrat, Majd Al Deen Li, Weijia Kishore, Preeti Faillace, Robert T Cureus Cardiology Type V hyperlipoproteinemia or multifactorial chylomicronemia syndrome is a rare lipid disorder triggered mainly by uncontrolled diabetes, obesity, poor diet, or particular medications. It is associated with an increased risk of acute pancreatitis and accelerated coronary artery disease which may manifest in younger age groups. We present a case of a 42-year-old male who presented to the emergency department (ED) complaining of a non-healing hand injury. Upon laboratory workup, the patient was found to have an elevated total cholesterol (TC) of 1129 mg/dL, very low levels of high-density lipoprotein (HDL) and triglycerides (TG) > 4000 mg/dL with an inability to calculate low-density lipoprotein (LDL). Lipoprotein electrophoresis revealed an actual TG level of > 7000 mg/dL, increased chylomicrons, normal B and pre-B-lipoproteins, and increased L-lipoproteins with an elevated Apolipoprotein B. Despite these derangements, the patient did not exhibit any abdominal complaints, demonstrating a normal lipase level. The physical exam was indicative of bilateral arcus senilis and obesity. Insulin drip was initiated along with intravenous (IV) hydration and it required 12 days to bring triglycerides down to less than 1000 mg/dL. The total cholesterol was also seen to be down trending to around 500 mg/dL and the HDL improved to 22 mg/dL. We present this case as a unique presentation of asymptomatic chylomicronemia resistant to insulin treatment with an elevated ApoB but with no evidence of pancreatitis or coronary artery disease. Cureus 2023-07-05 /pmc/articles/PMC10403339/ /pubmed/37546045 http://dx.doi.org/10.7759/cureus.41424 Text en Copyright © 2023, Mangeshkar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Mangeshkar, Shaunak
Nazarenko, Natalia
Varrias, Dimitrios
Spanos, Michail
Borkowski, Pawel
Alhuarrat, Majd Al Deen
Li, Weijia
Kishore, Preeti
Faillace, Robert T
A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title_full A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title_fullStr A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title_full_unstemmed A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title_short A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
title_sort case of type v hyperlipoproteinemia resistant to insulin treatment
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403339/
https://www.ncbi.nlm.nih.gov/pubmed/37546045
http://dx.doi.org/10.7759/cureus.41424
work_keys_str_mv AT mangeshkarshaunak acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT nazarenkonatalia acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT varriasdimitrios acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT spanosmichail acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT borkowskipawel acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT alhuarratmajdaldeen acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT liweijia acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT kishorepreeti acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT faillacerobertt acaseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT mangeshkarshaunak caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT nazarenkonatalia caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT varriasdimitrios caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT spanosmichail caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT borkowskipawel caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT alhuarratmajdaldeen caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT liweijia caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT kishorepreeti caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment
AT faillacerobertt caseoftypevhyperlipoproteinemiaresistanttoinsulintreatment